Miami, Florida, USA
2nd Edition of Cell & Gene Therapy World Conference(CGTWC) 2026
Scientific Sessions
Allogeneic vs Autologous Cell Therapies: Manufacturing, Efficacy, and Access
Autologous versus allogeneic therapies offer two separate, albeit complementary, trajectories in regenerative and personalized medicine. Each mechanism has its own merits and challenges, varying from scale and timeframe of manufacture to patient-specific efficacy in a global context. Identifying these differences is crucial to developing safe, effective, and economically sustainable therapeutic models.
At the CGTWC) In 2026, experts from biomanufacturing, clinical translation, and regulatory science will highlight new approaches to enhance both autologous and allogeneic platforms and advances toward the development of facility-based standardization for patient-accessible cell therapy.
Related Sessions
The 2ⁿᵈ Edition of the Cell & Gene Therapy World Conference (CGTWC 2026) is one o ...
Read More>>
